Taking it to the street
Results 61 - 70 of 757 : Previous 3 4 5 6 7 8 9 10 11 Next
Gilead Sciences Passes This Key Test
Look here for a clue.
One Reason the Street Should Love Biogen Idec's Earnings
Don't just count the cash. Time it.
Here's How Amgen May Be Failing You
Keep your eye on margins.
These two simple metrics can save you a lot of pain.
The 10 Best CEOs of the Past 10 Years, Part 3
This new service shines a light on the decade's best CEOs.
Our investing community's latest prime pick to avoid: Inhibitex.
The Highest-Rated Biotech Stocks
These stocks were given the highest marks in their industry by our community of investors.
Is Inhibitex the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
This Just In: Upgrades and Downgrades
Goldman piles on the "dump Dendreon" train.
Biogen Idec Passes This Key Test
Look here for a clue.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK